HansBiomed Financial Statements From 2010 to 2024
| 042520 Stock | KRW 12,960 330.00 2.61% |
Check HansBiomed financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among HansBiomed main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . HansBiomed financial statements analysis is a perfect complement when working with HansBiomed Valuation or Volatility modules.
HansBiomed |
HansBiomed Company Current Valuation Analysis
HansBiomed's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current HansBiomed Current Valuation | 184.7 B |
Most of HansBiomed's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, HansBiomed is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, HansBiomed has a Current Valuation of 184.7 B. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The current valuation for all Republic of Korea stocks is notably lower than that of the firm.
HansBiomed Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining HansBiomed's current stock value. Our valuation model uses many indicators to compare HansBiomed value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across HansBiomed competition to find correlations between indicators driving HansBiomed's intrinsic value. More Info.HansBiomed is number one stock in return on equity category among related companies. It is number one stock in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value HansBiomed by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for HansBiomed's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the HansBiomed's earnings, one of the primary drivers of an investment's value.About HansBiomed Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include HansBiomed income statement, its balance sheet, and the statement of cash flows. HansBiomed investors use historical funamental indicators, such as HansBiomed's revenue or net income, to determine how well the company is positioned to perform in the future. Although HansBiomed investors may use each financial statement separately, they are all related. The changes in HansBiomed's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on HansBiomed's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on HansBiomed Financial Statements. Understanding these patterns can help to make the right decision on long term investment in HansBiomed. Please read more on our technical analysis and fundamental analysis pages.
HansBiomed Corporation, together with its subsidiaries, engages in the research and development, production, and sale of medical materials for the procedure and the raw materials for medical supplies. HansBiomed Corporation was founded in 1993 and is based in Seoul, South Korea. HANS BIOMED is traded on Korean Securities Dealers Automated Quotations in South Korea.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of HansBiomed Correlation against competitors. Note that the HansBiomed information on this page should be used as a complementary analysis to other HansBiomed's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Complementary Tools for HansBiomed Stock analysis
When running HansBiomed's price analysis, check to measure HansBiomed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HansBiomed is operating at the current time. Most of HansBiomed's value examination focuses on studying past and present price action to predict the probability of HansBiomed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HansBiomed's price. Additionally, you may evaluate how the addition of HansBiomed to your portfolios can decrease your overall portfolio volatility.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |